Trial Profile
Randomized study of Taxane vs TS-1 in metastatic or recurrent breast cancer patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Jun 2019
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Docetaxel; Paclitaxel
- Indications Advanced breast cancer; HER2 negative breast cancer
- Focus Therapeutic Use
- Acronyms SELECT-BC
- 04 Jun 2019 Results of pooled analysis from two randomized phase 3 studies (SELECT BC-CONFIRM and SELECT BC) presented at the 55th Annual Meeting of the American Society of Clinical Oncology
- 02 Nov 2016 Results (n=380) analysing impacts of adverse events on health-related quality of life in patients from SELECT BC study, presented at the 19th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research.
- 23 Nov 2015 Results published in the Lancet Oncology